T. Rowe Price logo

T. Rowe Price

North America, Maryland, United States, Baltimore

Description

T. Rowe Price is a globally recognized independent investment management firm, headquartered in Baltimore, Maryland, with a long history primarily focused on public equities and fixed income. While not a traditional early-stage venture capital firm, the company has established a substantial presence in the private markets, particularly through its growth equity strategies. They act as a significant crossover investor, deploying capital into late-stage, high-growth technology companies that are often on the cusp of an initial public offering (IPO) or other major liquidity events. Their investment approach is characterized by deep fundamental research and a long-term perspective, aiming to partner with companies that have proven business models, strong management teams, and significant market opportunities.

The firm's private investments typically target companies that have already achieved considerable scale and revenue, distinguishing them from seed or Series A investors. T. Rowe Price often participates in, and frequently leads, large funding rounds for established private technology firms. For instance, they led a $250 million Series E round for Databricks in 2019, demonstrating their capacity to deploy substantial capital into promising ventures. Their portfolio includes numerous high-profile tech unicorns such as Snowflake, Airbnb, DoorDash, and Stripe, where they have often been key participants in multi-hundred-million-dollar funding rounds.

Given their strategic focus on growth equity, the typical "first check" from T. Rowe Price is significantly larger than those from early-stage venture capitalists. Their initial investments in a company generally range from approximately $25 million to upwards of $250 million, depending on the company's stage, capital needs, and the overall size of the funding round. This substantial check size reflects their preference for taking meaningful stakes in mature private companies, leveraging their extensive capital base, which manages over $1.4 trillion in assets globally as of December 31, 2023. They are a crucial source of capital for companies seeking to scale rapidly and prepare for public market entry.

Investor Profile

T. Rowe Price has backed more than 346 startups, with 18 new investments in the last 12 months alone. The firm has led 89 rounds, about 26% of its total and boasts 141 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series D, Series B rounds (top funding stages).
  • Majority of deals are located in United States, India, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 4 rounds in the past year.
  • Typical check size: $25M – $250M.

Stage Focus

  • Series C (17%)
  • Series D (16%)
  • Series B (11%)
  • Series E (10%)
  • Series Unknown (9%)
  • Series F (9%)
  • Private Equity (8%)
  • Post Ipo Equity (6%)
  • Series G (5%)
  • Series A (3%)

Country Focus

  • United States (92%)
  • India (2%)
  • United Kingdom (1%)
  • Australia (1%)
  • Canada (1%)
  • Germany (1%)
  • France (1%)
  • China (1%)
  • Colombia (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Pharmaceutical
  • Life Science
  • Saas
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does T. Rowe Price frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 28
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 30
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 24
Dragoneer Investment Group
North America, California, United States, San Francisco
Co-Investments: 24
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 27
BlackRock
North America, New York, United States, New York
Co-Investments: 33
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 26
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 31
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 34
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 96

Which angels does T. Rowe Price often collaborate with?

MV
North America, Washington, United States, Seattle
Shared Deals: 2
Shared Deals: 1
ES
North America, California, United States, Mountain View
Shared Deals: 3
JL
North America, United States
Shared Deals: 1
AG
North America, New Jersey, United States, New Brunswick
Shared Deals: 1
SS
North America, California, United States, Los Angeles
Shared Deals: 2
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
OV
North America, California, United States, San Francisco
Shared Deals: 1
David J. Adelman
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 2
SP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by T. Rowe Price?

Ramp

New York, New York, United States

Ramp is a financial operations platform designed to save companies time and money

FinanceFinancial ServicesFinTech
Series EJul 30, 2025
Amount Raised: $500,000,000
Farmers Business Network

San Carlos, California, United States

Farmers Business Network is a digital marketplace that helps farmers buy inputs, access financing, and join marketing programs.

AgricultureAgTechE-CommerceFarmingMarketplaceSustainability
Series UnknownJul 28, 2025
Amount Raised: $50,000,000
MapLight Therapeutics

Palo Alto, California, United States

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

BiopharmaBiotechnologyLife ScienceMedical
Series DJul 28, 2025
Amount Raised: $372,500,000
Avalyn Pharma

Seattle, Washington, United States

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

BiopharmaBiotechnologyMedicalPharmaceutical
Series DJul 22, 2025
Amount Raised: $100,000,000
Broadstreet Partners

Columbus, Ohio, United States

Broadstreet Partners is a brokerage firm that focuses on investment and acquisitions with agencies for their financial support.

Angel InvestmentConsultingFinanceFinancial ServicesSmall and Medium Businesses
Private EquityJul 18, 2025
iCapital Network

New York, New York, United States

iCapital Network is a fintech platform for alternative investments and investors.

Asset ManagementBankingFinancial ServicesFinTech
Private EquityJul 10, 2025
Amount Raised: $820,000,000
Kardium

Burnaby, British Columbia, Canada

Kardium is a medical solutions company that develops a globe pulsed field system for the diagnosis and treatment of atrial fibrillation.

HardwareHealth DiagnosticsManufacturingMedicalMedical Device
Private EquityJul 2, 2025
Amount Raised: $249,198,899
Stash

New York, New York, United States

Stash develops a personal finance application to combine banking, investing, and advice into one platform.

AppsBankingFinTechMobile AppsPersonal Finance
Series HMay 12, 2025
Amount Raised: $146,000,000
HUB International

Chicago, Illinois, United States

HUB International is an insurance brokerage company that offers employee benefits, business, and personal insurance products and services.

Financial ServicesInsuranceInsurTechRisk Management
Private EquityMay 12, 2025
Amount Raised: $1,600,000,000
Nuro

Mountain View, California, United States

Nuro is a robotics company specializing in the development of autonomous driving technologies.

Artificial Intelligence (AI)Autonomous VehiclesRoboticsTransportation
Series EApr 9, 2025
Amount Raised: $106,000,000